Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001993350-23-000001
Filing Date
2023-09-14
Accepted
2023-09-14 13:01:07
Documents
1
Effectiveness Date
2023-09-14
Items
Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4742
  Complete submission text file 0001993350-23-000001.txt   5872
Mailing Address 99 PASADENA AVENUE SUITE 5 SOUTH PASADENA CA 91030
Business Address 99 PASADENA AVENUE SUITE 5 SOUTH PASADENA CA 91030 626-678-3368
Balto Pharmaceuticals, Inc. (Filer) CIK: 0001993350 (see all company filings)

EIN.: 474826584 | State of Incorp.: CA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-492095 | Film No.: 231254596